The major dermatomyositis‐specific mi‐2 autoantigen is a presumed helicase involved in transcriptional activation

Abstract

The molecular characterization of the 218-kd Mi-2 antigen may contribute to our understanding of autoimmune phenomena in DM. The use of immunoreactive recombinant proteins allows structural and functional studies of the helicase and the development of sensitive and accurate antibody screening tests.